-
NEOPLASMS Guidelines
ID: 4Tbr5NpisV
From:
-
Diagnosis Treatment Patients with Primary and Metastatic Breast Cancer
ID: 5MFNshesuW
From:
-
Linee Guida AIOM DELLA
ID: IttgaDpUYo
From:
-
Personalhistorisk Tidsskrift 8. rk 6. bd 3.-4. hf
ID: lCw4qasMFo
From:
-
Personalhistorisk Tidsskrift 8. rk 6. bd 3.-4. hf
ID: OcZbEXKK6n
From:
-
Items Year is 2020 - SORA
ID: 768takQDIt
From:
-
ID: D10wziSZXs
From:
-
NEOPLASMS Guidelines
ID: q7oB6Eq2IV
From:
-
Personalhistorisk Tidsskrift
ID: Pc7u3sb8bJ
From:
-
Items Year is 2020 - SORA
ID: AU1RRjO5Xg
From:
-
2018
ID: XsL9AvPau3
From:
-
Linee Guida AIOM DELLA
ID: ObYLeXPh7X
From:
-
NEOPLASMS Guidelines
ID: jRX7eXjTXe
From:
-
Personalhistorisk Tidsskrift 8. rk 6. bd 3.-4. hf
ID: Lc9HcHkvbI
From:
-
Linee Guida AIOM DELLA
ID: H3MXYpJOfg
From:
-
Items Year is 2020 - SORA
ID: ZJLrcfdXIy
From:
-
Linee Guida AIOM DELLA
ID: fiUwLLzQgt
From:
-
Diagnosis Treatment Patients with Primary and Metastatic Breast Cancer
ID: Pa0U2zNuCt
From:
-
Personalhistorisk Tidsskrift 8. rk 6. bd 3.-4. hf
ID: Wzyg3CXLde
From:
-
NEOPLASMS Guidelines
ID: tX4kJWxl4R
From:
-
Diagnosis Treatment Patients with Primary and Metastatic Breast Cancer
ID: vBJF7JRgeY
From: